AlphaYouBMRN: Friberg Gregory R discloses securities transactions
By AlphaYouPublished Form 4
Friberg Gregory R
Reporting filer
Friberg Gregory R reported Tax/exercise withholding in BIOMARIN PHARMACEUTICAL INC: 4086 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 1, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Friberg Gregory R | 2026-09-30 | F | Tax/exercise withholding | 4086 | 60 | 47,732 | 1 day | Filed terms
|
Common Stock
- Owner
- Friberg Gregory R
- Date
- 2026-09-30
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 4086
- Price
- 60
- Following holdings
- 47,732
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-30
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- transaction Shares: 4086
- transaction Price Per Share: 60
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 47732
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Friberg Gregory R: EVP, Chief R&D Officer.
Original sources
Prepared automatically from public filing data. Report a correction.